Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Deborah Collyar: What's In It for Patients?

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Advertisement

Advertisement




Feb
05
Today In Oncology
Addition of Palbociclib to Standard Therapy in Hormone Receptor–Positive, HER2-Positive Metastatic Breast Cancer
ASH 2025: Highlights in Relapsed/Refractory Multiple Myeloma
World Cancer Day 2026 UICCs Campaign United by Unique
Oxybutynin May Improve ADT-Induced Hot Flashes in Patients With Prostate Cancer
American College of Surgeons Publishes Annual NCDB Report
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo